Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2005
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050203092 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods
09/15/2005US20050203083 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; e.g. Biphenyl-2-ylcarbamic acid 1-(2-[5-(4-hydroxybenzylamino)pentylcarbamoyl]ethyl)piperidin-4-yl ester; long duration of action; reduced side effects, such as dry-mouth and constipation
09/15/2005US20050203079 Serotonin (5-HT) 2c receptors; antidepressants, anxiolytic agents; 3-(3,4-Dichloro-phenyl)-3-hydroxy-1-[4-methoxy-3-(2-piperidin-1-yl-ethoxy)-phenyl]-pyrrolidin-2-one for example
09/15/2005US20050203078 Inhibitors of factor Xa or related serine proteases; thrombosis; benzamide derivatives with benzimidazole, indole or imidazo(1,2-a)pyridine rings; e.g. 4-(azepan-2-on-1-yl)-N-[(1R)-1-(5-chloro-1H-benzimidazol-2-yl)-2-methoxy-ethyl]-3-methyl-benzamide
09/15/2005US20050203031 Useful for the treatment of type 2 diabetes, impaired glucose tolerance and certain other conditions
09/15/2005US20050202973 Aryl-alkyne compounds as herbicides
09/15/2005US20050198773 Magnetism to control compressive friction checks for rods including those of door closers
09/15/2005DE102004010207A1 New 4-benzimidazolyl-3(2H)-pyridazinone derivatives are kinase inhibitors, especially useful for treatment of cancer
09/15/2005DE102004010132A1 Piperidinderivate Piperidine
09/15/2005DE102004004972B3 Heterocyclisch substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Heterocyclic-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, to processes for their preparation and their use as medicaments
09/15/2005CA2558600A1 A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4
09/15/2005CA2558375A1 Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/15/2005CA2558278A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005CA2558274A1 Cycloalkanopyridine derivative
09/15/2005CA2557858A1 Amino cyclopropane carboxamide derivatives as bradykinin antagonists
09/15/2005CA2557645A1 Caspase inhibitors and uses thereof
09/15/2005CA2557634A1 Stable capsule preparation
09/15/2005CA2557322A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005CA2557304A1 Ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
09/15/2005CA2557302A1 Pyridinamide derivative as kinase inhibitors
09/15/2005CA2557270A1 Pyrrole-derivatives as factor xa inhibitors
09/15/2005CA2556387A1 Bicyclic anthranilamide derivatives useful as insecticides
09/15/2005CA2555712A1 Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein
09/15/2005CA2555161A1 Novel 4-benzimidazol-2-yl-pyridazin-3-one derivatives
09/15/2005CA2554772A1 Crystal forms of e-2-methoxy-n-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide
09/15/2005CA2553252A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides
09/14/2005EP1574569A1 Three-dimensional structure of lipocalin-type prostaglandin d synthase and utilization of the same
09/14/2005EP1574511A1 2-Pyridinylethylcarboxamide derivatives and their use as fungicides
09/14/2005EP1574510A1 Substituted pyridine herbicides
09/14/2005EP1574501A1 Quinolinone derivatives, pharmaceutical compositions containing them and their use
09/14/2005EP1574205A2 Composition comprising a chromophore of azo or tri(hetero)arymethane type
09/14/2005EP1572693A1 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
09/14/2005EP1572691A1 Pyrazole compounds as integrin receptor antagonists derivatives
09/14/2005EP1572686A1 Anthranilic acid amide derivatives and their pharmaceutical use
09/14/2005EP1572683A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572682A2 Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2
09/14/2005EP1572681A1 3-substituted-4-pyrimidone derivatives
09/14/2005EP1572680A2 Solid states of pantoprazole sodium, known pantoprazole sodium hydrates, processes for their preparation.
09/14/2005EP1572678A2 Substituted n-phenyl sulfonamide bradykinin antagonists
09/14/2005EP1572669A2 2,5-diketopiperazines for the treatment of obesity
09/14/2005EP1572668A2 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
09/14/2005EP1572667A1 Cathepsin cysteine protease inhibitors and their use
09/14/2005EP1572664A1 Pyrazole compounds
09/14/2005EP1572662A1 Pyrazole and imidazole compounds and uses thereof
09/14/2005EP1572656A2 Compounds useful as pesticides
09/14/2005EP1572651A1 Compounds useful as pesticides
09/14/2005EP1572650A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572648A1 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists
09/14/2005EP1572642A1 3-pyrrolyl urea derivatives and their use as antiviral agents
09/14/2005EP1572299A1 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
09/14/2005EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
09/14/2005EP1572215A1 Benzo[d]azepine derivatives for the treatment of neurological disorders
09/14/2005EP1572212A2 Quinoline compounds for use in mch receptor related disorders
09/14/2005EP1572210A1 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
09/14/2005EP1572209A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists
09/14/2005EP1572207A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
09/14/2005EP1572199A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
09/14/2005EP1572112A2 3-(pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openers
09/14/2005EP1572072A2 Methods of treating infection by drug resistant bacteria
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005EP1461318B1 Tetrahydroquinoline analogues as muscarinic agonists
09/14/2005EP1341781B1 Antimicrobial quinolones
09/14/2005EP1289954B1 Serine protease inhibitors
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005EP1091737B1 Use of 1-(3,3-diphenylpropionyl)-4-benzhydril piperazine in the treatment of pain
09/14/2005EP1071420B1 Indolyl-3-glyoxylic acid derivatives with antitumoral activity
09/14/2005CN1668703A Charge transport compositions on the basis of triarylmethanes and their use in electronic devices
09/14/2005CN1668616A Charge transport compositions comprising fluorizated quinazoline derivatives
09/14/2005CN1668603A Pyridazin-3(2h)-one derivatives as PDE4 inhibitors
09/14/2005CN1668602A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
09/14/2005CN1668601A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors
09/14/2005CN1668600A 5-substituted isoquinoline derivatives
09/14/2005CN1668590A 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
09/14/2005CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
09/14/2005CN1668585A 3, 6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
09/14/2005CN1668584A Pyrrole derivatives as antimycobacterial compounds
09/14/2005CN1668306A 4-4(methylpiperazin-1-ylmethyl)-n-[4-methyl-3-((pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating mutated-RET kinase associated diseases
09/14/2005CN1668304A Crystalline 2, 5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
09/14/2005CN1668302A Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors
09/14/2005CN1668300A Spirocyclic piperidines as MCH1 antagonists and uses thereof
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/14/2005CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/14/2005CN1666988A Environmental protection reactive dyeing and use thereof
09/14/2005CN1666983A Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest contollers and a method for using the same
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/13/2005US6943254 Reaction of the diazonium salt of an aminopyridine or aminobenzene in which the benzene ring bears one or more electron-withdrawing groups with a mixture of thionyl chloride in water, in the presence of an electron transfer-catalyst
09/13/2005US6943252 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
09/13/2005US6943251 Preparation of salts of 4-[4-[(1R)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3S)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]
09/13/2005US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease
09/13/2005US6943187 Shampoos for treating alopecia
09/13/2005US6943183 Antiproliferative agnets; anticancer agents; skin disorders; restenosis
09/13/2005US6943180 Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors
09/13/2005US6943179 Biurethane derivatives
09/13/2005US6943176 Heterocyclic derivatives
09/13/2005US6943172 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders
09/13/2005US6943169 Quinolinone derivatives and uses thereof
09/13/2005US6943168 Calcium channel inhibitors comprising benzhydril spaced from piperazine
09/13/2005US6943162 Osteoporosis; cardiovascular disorders; anticancer agents;incontinence
09/13/2005US6943161 For prophylaxis and therapy of inflammation, asthma, arthritis, diabetes, atherosclerosis, ocular diseases, restenosis, autoimmune responses, multiple sclerosis, psoriasis, human cancers, fibrosis of liver, lung and kidney